The new frontier of genome engineering with CRISPR-Cas9
The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [3]
In the citing paper
“The CRISPR/Cas9 genome-editing system provides us an unprecedented opportunity to target and modify genomic sequences with high levels of efficacy and specificity [151,152,153,154,155].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [152]
In the citing paper
“gene-editing techniques such as CRISPR-Cas9 [11], have led to a “democratization” of molecular biology, with functional and genomic analyses now possible in a wide range of species”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“This outlook has changed dramatically in the last few years due to the introduction of novel methods that can be directly applied to a wide variety of species.”
From Back to the Basics: Cnidarians Start to Fire (2017) · cites this paper as [11]
In the citing paper
“Cas9:sgRNA recognizes the protospacer-adjacent motif (PAM) sequence and a complementary 20-nucleotide genomic sequence and induces double-strand DNA breaks, which are repaired by error-prone nonhomologous end-joining (NHEJ) or precise homology-directed repair (HDR)2,5.”
From Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo (2016) · cites this paper as [2]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 5×
“Targeting with multiple sgRNAs—referred to as multiplexing—was also successfully achieved (75, 86).”
InfluentialCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947 · cited 3×
“provided the first experimental evidence of CRISPRCas–mediated adaptive immunity (45).”
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · cited 1×
“This approach was also used to identify genes essential for cell viability in cancer and pluripotent stem cells (102).”
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“coli, whole-genome sequencing showed that there were no detectable off-target effects (127).”
Self-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Specifically, fusion of dCas9 to effector domains including VP64 or KRAB allowed stable and efficient transcriptional activation or repression, respectively, in human and yeast cells (129).”
Self-citationWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153 · cited 2×
“Manyoftheseapplicationshavebeendiscussedinre-centreviews( 91 – 93 ).”
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856 · cited 1×
“A genomescale lentiviral sgRNA library was developed to generate a pooled loss-of-function genetic screening approach suitable for both positive and negative selection (100, 101).”
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769 · cited 4×
“DNAtarget recognition requires both base pairing to the crRNA sequence and the presence of a short sequence (PAM) adjacent to the targeted sequence in the DNA ( 64 , 65 ) (Fig.”
InfluentialCRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563 · cited 4×
“In 2011 (66), trans-activating crRNA (tracrRNA) —a small RNA that is trans-encoded upstream of the type II CRISPR-Cas locus in Streptococcus pyogenes—was reported to be essential for crRNA maturation by ribonuclease III and Cas9, and tracrRNA-mediated activation of crRNA maturation was found to confer sequence-specifi…”
InfluentialSelf-citationRepetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes.
Miller, J., McLachlan, A. D., & Klug, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03825.x · Cited by 2,476
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., & Bonas, U. (2009) · Science · doi:10.1126/science.1178811 · Cited by 2,470
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460 · cited 2×
“The type I and type III systems use a large complex of Cas proteins for crRNA-guided targeting ( 47 , 59 – 63 ).”
Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., & Nakata, A. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.12.5429-5433.1987 · Cited by 2,421 · cited 1×
“…laboratories in the mid-2000s began investigating CRISPRs (clustered regularly interspaced palindromic repeats), which had been described in 1987 by Japanese researchers as a series of short direct repeats interspaced with short sequences in the genome of Escherichia coli ( 34 ) (Fig.”
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331 · cited 1×
“Within this overall theme, three CRISPRCas system types (I, II, and III) use distinct molecular mechanisms to achieve nucleic acid recognition and cleavage (54, 55).”
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328 · cited 2×
“thermophilus Cas9 is essential for defense against viral invasion (45, 66), might be responsible for introducing DSBs into invading plasmids and phages (67), enables in vivo targeting of temperate phages and plasmids in bacteria (66, 68), and requires the HNH and RuvC domains to interfere with plasmid transformation e…”
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098 · cited 4×
“1016/ S0092-8674(85)80011-8; pmid: 3886163”
InfluentialSelf-citationZinc Finger-DNA Recognition: Crystal Structure of a Zif268-DNA Complex at 2.1 Å
Pavletich, N. P., & Pabo, C. O. (1991) · Science · doi:10.1126/science.2028256 · Cited by 2,061
Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements
Mojica, F. J. M., D�ez-Villase�or, C., Garc�a-Mart�nez, J., & Soria, E. (2005) · Journal of Molecular Evolution · doi:10.1007/s00239-004-0046-3 · Cited by 2,042
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
A Simple Cipher Governs DNA Recognition by TAL Effectors
Moscou, M. J., & Bogdanove, A. J. (2009) · Science · doi:10.1126/science.1178817 · Cited by 1,988
Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System
Chen, B., Gilbert, L. A., Cimini, B. A., Schnitzbauer, J., Zhang, W., Li, G.-W., Park, J., Blackburn, E. H., Weissman, J. S., Qi, L. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.12.001 · Cited by 1,963 · cited 1×
“An enhanced green fluorescent protein– tagged dCas9 protein and a structurally optimized sgRNA were shown to produce robust imaging of repetitive and nonrepetitive elements in telomeres and coding genes in living cells (131).”
Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain.
Kim, Y. G., Cha, J., & Chandrasegaran, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1156 · Cited by 1,889 · cited 1×
“At around the same time, the initial reports of zinc finger – mediated DNA binding ( 26 , 27 ) led to the creation of modular DNA recognition proteins that, when coupled to the sequence-independent nuclease domain of the restriction enzyme FokI, could function as site-specific nucleases ( 28 ).”
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13011 · Cited by 1,822
Self-citationIdentification of genes that are associated with DNA repeats in prokaryotes
Jansen, R., Embden, J. D. A. V., Gaastra, W., & Schouls, L. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02839.x · Cited by 1,802 · cited 1×
“…are transcribed ( 41 ) and the observation that cas (CRISPR-associated) genes encode proteins with putative nuclease and helicase domains ( 38 , 40 , 42 , 43 ), it was proposed that CRISPR-Cas is an adaptive defense system that might use antisense RNAs as memory signatures of past invasions ( 44 ).”
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA
Marraffini, L. A., & Sontheimer, E. J. (2008) · Science · doi:10.1126/science.1165771 · Cited by 1,642
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596
Bolotin, A., Quinquis, B., Sorokin, A., & Ehrlich, S. D. (2005) · Microbiology · doi:10.1099/mic.0.28048-0 · Cited by 1,558
Li, J.-F., Norville, J. E., Aach, J., McCormack, M., Zhang, D., Bush, J., Church, G. M., & Sheen, J. (2013) · Nature Biotechnology · doi:10.1038/nbt.2654 · Cited by 1,510
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487 · cited 1×
“The amount of Cas9 enzyme expressed in the cell is an important factor in tolerance to mismatches (138).”
Self-citationSchwank, G., Koo, B.-K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C. K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.002 · Cited by 1,424 · cited 1×
“(organoids) harboring the desired, exact genetic change (104).”
Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases
Cho, S. W., Kim, S., Kim, Y., Kweon, J., Kim, H. S., Bae, S., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.162339.113 · Cited by 1,356
Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,323
Jiang, W., Zhou, H., Bi, H., Fromm, M., Yang, B., & Weeks, D. P. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt780 · Cited by 1,247
CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing
Montague, T. G., Cruz, J. M., Gagnon, J. A., Church, G. M., & Valen, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku410 · Cited by 1,234
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230 · cited 3×
“A crystal structure of the smaller Cas9 protein from Actinomyces, for example, showed how natural variation created a streamlined enzyme, setting the stage for future engineered Cas9 variants (77).”
InfluentialSelf-citationPhage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus
Deveau, H., Barrangou, R., Garneau, J. E., Labonté, J., Fremaux, C., Boyaval, P., Romero, D. A., Horvath, P., & Moineau, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.01412-07 · Cited by 1,213 · cited 1×
“Theprotospacer adjacent motif (PAM), a short sequence motif adjacent to the crRNA-targeted sequence on the invading DNA, plays an essential role in the stages of adaptation and interference in type I and type II systems ( 39 , 56 – 58 ).”
Pourcel, C., Salvignol, G., & Vergnaud, G. (2005) · Microbiology · doi:10.1099/mic.0.27437-0 · Cited by 1,201 · cited 1×
“and helicase domains (38, 40, 42, 43), it was proposed that CRISPR-Cas is an adaptive de-”
Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I., & Koonin, E. V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-7 · Cited by 1,199 · cited 3×
“CRISPRs contain viral sequences, cas genes identified, hypothesis ( 35 , 36 , 38–40 , 43 , 44 )”
Cas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt520 · Cited by 1,145 · cited 1×
“CRISPRi has been used to repress multiple target genes simultaneously, and its effects are reversible ( 127 – 130 ).”
Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease
Nekrasov, V., Staskawicz, B., Weigel, D., Jones, J. D. G., & Kamoun, S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2655 · Cited by 1,127
Niu, Y., Shen, B., Cui, Y., Chen, Y., Wang, J., Wang, L., Kang, Y., Zhao, X., Si, W., Li, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.01.027 · Cited by 1,033 · cited 1×
“The technology can also facilitate the generation of mouse (120–122) and rat (123, 124) models better suited to pharmacological studies and the understanding of human diseases, as well as pigs (125) andmonkeys (126).”
RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex
Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & Terns, M. P. (2009) · Cell · doi:10.1016/j.cell.2009.07.040 · Cited by 1,031 · cited 1×
“The type I and type III systems use a large complex of Cas proteins for crRNA-guided targeting ( 47 , 59 – 63 ).”
Haft, D. H., Selengut, J., Mongodin, E. F., & Nelson, K. E. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010060 · Cited by 979
Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination
Smithies, O., Gregg, R. G., Boggs, S. S., Koralewski, M. A., & Kucherlapati, R. S. (1985) · Nature · doi:10.1038/317230a0 · Cited by 977
Genome Engineering of Drosophila with the CRISPR RNA-Guided Cas9 Nuclease
Gratz, S. J., Cummings, A. M., Nguyen, J. N., Hamm, D. C., Donohue, L. K., Harrison, M. M., Wildonger, J., & O’Connor-Giles, K. M. (2013) · Genetics · doi:10.1534/genetics.113.152710 · Cited by 976 · cited 1×
“Efficient genome engineering to allow targeted genome modifications in the germ lines of animal models such as fruit flies ( 113 , 114 ), zebrafish ( 94 , 115 ), nematodes ( 116 ), salamanders ( 117 ), and frogs ( 118 , 119 ) is now possible with the development of the CRISPR-Cas9 technology.”
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing
Tsai, S. Q., Wyvekens, N., Khayter, C., Foden, J. A., Thapar, V., Reyon, D., Goodwin, M. J., Aryee, M. J., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2908 · Cited by 952 · cited 1×
“at a defined distance apart (149, 150); and shorter sgRNAs truncated by”
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Yin, H., Xue, W., Chen, S., Bogorad, R. L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P. A., Jacks, T., & Anderson, D. G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2884 · Cited by 951 · cited 1×
“An exciting harbinger of future research in this area is the recent demonstration that Cas9–guide RNA complexes, when injected into adult mice, provided sufficient editing in the liver to alleviate a genetic disorder (153).”
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
Wu, X., Scott, D. A., Kriz, A. J., Chiu, A. C., Hsu, P. D., Dadon, D. B., Cheng, A. W., Trevino, A. E., Konermann, S., Chen, S., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2889 · Cited by 944 · cited 1×
“Results showed that in both human embryonic kidney (HEK293) cells (83) and mouse embryonic stem cells (mESCs) (84), a catalytically inactive version of Cas9 bound to many more sites than those matching the sequence of the sgRNA used in each case.”
FORMATION OF A THREE-STRANDED POLYNUCLEOTIDE MOLECULE
Felsenfeld, G., Davies, D. R., & Rich, A. (1957) · Journal of the American Chemical Society · doi:10.1021/ja01565a074 · Cited by 931 · cited 1×
“Building on the original description of triple helix formation by Rich and colleagues in the late 1950s ( 10 , 11 ), oligonucleotides coupled to chemical cleavage or cross-linking reagents such as bleo-mycin and psoralen were shown to be useful for site-specific chromosome modification in yeast and…”
Heritable genome editing in C. elegans via a CRISPR-Cas9 system
Friedland, A. E., Tzur, Y. B., Esvelt, K. M., Colaiácovo, M. P., Church, G. M., & Calarco, J. A. (2013) · Nature Methods · doi:10.1038/nmeth.2532 · Cited by 899
Highly Efficient Targeted Mutagenesis of Drosophila with the CRISPR/Cas9 System
Bassett, A. R., Tibbit, C., Ponting, C. P., & Liu, J.-L. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.020 · Cited by 861 · cited 1×
“Efficient genome engineering to allow targeted genome modifications in the germ lines of animal models such as fruit flies (113, 114), zebrafish (94, 115), nematodes (116), salamanders (117), and frogs (118, 119) is now possible with the development of the CRISPR-Cas9 technology.”
Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases
Bibikova, M., Golic, M., Golic, K. G., & Carroll, D. (2002) · Genetics · doi:10.1093/genetics/161.3.1169 · Cited by 860
Guilinger, J. P., Thompson, D. B., & Liu, D. R. (2014) · Nature Biotechnology · doi:10.1038/nbt.2909 · Cited by 836
The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli
Sapranauskas, R., Gasiunas, G., Fremaux, C., Barrangou, R., Horvath, P., & Siksnys, V. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr606 · Cited by 834
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Barrangou, R., & Marraffini, L. A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.011 · Cited by 832
Enhancing Gene Targeting with Designed Zinc Finger Nucleases
Bibikova, M., Beumer, K., Trautman, J. K., & Carroll, D. (2003) · Science · doi:10.1126/science.1079512 · Cited by 823 · cited 1×
“When designed to recognize a chromosomal sequence, such zinc finger nucleases (ZFNs) were found to be effective at inducing genomic sequence changes in Drosophila and mammalian cells (29, 30).”
Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos
Chang, N., Sun, C., Gao, L., Zhu, D., Xu, X., Zhu, X., Xiong, J.-W., & Xi, J. J. (2013) · Cell Research · doi:10.1038/cr.2013.45 · Cited by 820 · cited 1×
“Efficient genome engineering to allow targeted genome modifications in the germ lines of animal models such as fruit flies (113, 114), zebrafish (94, 115), nematodes (116), salamanders (117), and frogs (118, 119) is now possible with the development of the CRISPR-Cas9 technology.”
Mojica, F. J. M., Díez‐Villaseñor, C., Soria, E., & Juez, G. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01838.x · Cited by 820
RNA-Guided Genome Editing in Plants Using a CRISPR–Cas System
Xie, K., & Yang, Y. (2013) · Molecular Plant · doi:10.1093/mp/sst119 · Cited by 805 · cited 1×
“Since its demonstration as a genome editing tool in Arabidopsis thaliana and Nicotiana benthamiana ( 105 , 106 ), editing has been demonstrated in crop plants including rice, wheat, andsorghumaswellassweetorangeandliverwort ( 107 – 111 ).”
Zhang, H., Zhang, J., Wei, P., Zhang, B., Gou, F., Feng, Z., Mao, Y., Yang, L., Zhang, H., Xu, N., et al. (2014) · Plant Biotechnology Journal · doi:10.1111/pbi.12200 · Cited by 792
Rouet, P., Smih, F., & Jasin, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8096 · Cited by 791
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing
Esvelt, K. M., Mali, P., Braff, J. L., Moosburner, M., Yaung, S. J., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2681 · Cited by 786 · cited 2×
“The reported collection of Cas9 orthologs constitutes a large source of CRISPR-Cas9 systems for multiplex gene targeting, and several orthologous CRISPR-Cas9 systems have already been applied successfully for genome editing in human cells [Neisseria meningitidis (73, 74), S.”
Diversity, Activity, and Evolution of CRISPR Loci in Streptococcus thermophilus
Horvath, P., Romero, D. A., Coûté-Monvoisin, A.-C., Richards, M., Deveau, H., Moineau, S., Boyaval, P., Fremaux, C., & Barrangou, R. (2008) · Journal of Bacteriology · doi:10.1128/jb.01415-07 · Cited by 780
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
Kuscu, C., Arslan, S., Singh, R., Thorpe, J., & Adli, M. (2014) · Nature Biotechnology · doi:10.1038/nbt.2916 · Cited by 777 · cited 1×
“Re-sults showed that in both human embryonic kidney (HEK293) cells ( 83 ) and mouse embryonic stem cells (mESCs) ( 84 ), a catalytically inactive version of Cas9 bound to many more sites than those matching the sequence of the sgRNA used in each case.”
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N. S., Cai, W., Yang, G., Bronson, R., Crowley, D. G., et al. (2014) · Nature · doi:10.1038/nature13589 · Cited by 776 · cited 1×
“An improved method to generate liver cancer or myeloid malignancy models in mice facilitated by CRISPR-Cas9 was recently reported (98, 99).”
Replacement of chromosome segments with altered DNA sequences constructed in vitro.
Scherer, S., & Davis, R. W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.10.4951 · Cited by 769 · cited 1×
“2010 onward Increasing use of TALENs for genome engineering 1979 Gene replacement in yeast (1) 1996–2003 Zinc-finger nucleases for genome engineering (28–30) 2007 CRISPR-Cas is bacterial immune system (45) 2012 CRISPR-Cas9 is RNA-guided DNA endonuclease (64)”
Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects
Shen, B., Zhang, W., Zhang, J., Zhou, J., Wang, J., Chen, L., Wang, L., Hodgkins, A., Iyer, V., Huang, X., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2857 · Cited by 769 · cited 1×
“…a double-nicking approach consisting of using the nickase variant of Cas9 with a pair of offset sgRNAs properly positioned on the target DNA ( 146 – 148 ); an sgRNA-guided dCas9 fused to the FokI nuclease where two fused dCas9-FokI monomers ( 149 , 150 ); and shorter sgRNAs truncated by two or…”
Cheng, A. W., Wang, H., Yang, H., Shi, L., Katz, Y., Theunissen, T. W., Rangarajan, S., Shivalila, C. S., Dadon, D. B., & Jaenisch, R. (2013) · Cell Research · doi:10.1038/cr.2013.122 · Cited by 751 · cited 1×
“The technology can also facilitate the generation of mouse ( 120 – 122 ) and rat ( 123 , 124 ) models better suited to pharmacological studies and the understanding of human diseases, as well as pigs ( 125 )andmonkeys( 126 ).”
High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
Zhou, Y., Zhu, S., Cai, C., Yuan, P., Li, C., Huang, Y., & Wei, W. (2014) · Nature · doi:10.1038/nature13166 · Cited by 733 · cited 1×
“A genomescale lentiviral sgRNA library was developed to generate a pooled loss-of-function genetic screening approach suitable for both positive and negative selection (100, 101).”
Unravelling the structural and mechanistic basis of CRISPR–Cas systems
van der Oost, J., Westra, E. R., Jackson, R. N., & Wiedenheft, B. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3279 · Cited by 714
Sequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease
Haurwitz, R. E., Jinek, M., Wiedenheft, B., Zhou, K., & Doudna, J. A. (2010) · Science · doi:10.1126/science.1192272 · Cited by 710
Self-citationEfficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis
Hou, Z., Zhang, Y., Propson, N. E., Howden, S. E., Chu, L.-F., Sontheimer, E. J., & Thomson, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313587110 · Cited by 681 · cited 1×
“The reported collection of Cas9 orthologs constitutes a large source of CRISPR-Cas9 systems for multiplex gene targeting, and several orthologous CRISPR-Cas9 systems have already been applied successfully for genome editing in human cells [Neisseria meningitidis (73, 74), S.”
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
Ramakrishna, S., Kwaku Dad, A.-B., Beloor, J., Gopalappa, R., Lee, S.-K., & Kim, H. (2014) · Genome Research · doi:10.1101/gr.171264.113 · Cited by 655 · cited 1×
“cell-penetrating peptides to enable rapid and timed editing (89, 152), and transgenic organisms that express Cas9 from inducible promoters are being tested.”
Programmable RNA recognition and cleavage by CRISPR/Cas9
O’Connell, M. R., Oakes, B. L., Sternberg, S. H., East-Seletsky, A., Kaplan, M., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13769 · Cited by 632 · cited 1×
“In addition, it has been possible to induce Cas9 to bind single- strandedRNAinaprogrammablefashionbyusingshortDNAoligonucleotidescontainingPAMse-quences(PAMmers)toactivatetheenzyme,sug-gestingnewwaystotargettranscriptswithout prioraffinitytagging( 135 ).”
Self-citationHigh frequency targeting of genes to specific sites in the mammalian genome
THOMAS, K. (1986) · Cell · doi:10.1016/0092-8674(86)90463-0 · Cited by 621
Correction of a genetic disease in mouse via use of CRISPR-Cas9
Wu, Y., Liang, D., Wang, Y., Bai, M., Tang, W., Bao, S., Yan, Z., Li, D., & Li, J. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.10.016 · Cited by 614 · cited 1×
“A dominant mutation in the Crygc gene responsible for cataracts was successfully corrected in mice (103).”
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Cradick, T. J., Fine, E. J., Antico, C. J., & Bao, G. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt714 · Cited by 590
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) · Scientific Reports · doi:10.1038/srep02510 · Cited by 565 · cited 1×
“targeted CRISPR-Cas9 technique was shown to efficiently cleave and mutate the long terminal repeat sites of HIV-1 and also to remove internal viral genes from the chromosome of infected cells (132, 133).”
Heckl, D., Kowalczyk, M. S., Yudovich, D., Belizaire, R., Puram, R. V., McConkey, M. E., Thielke, A., Aster, J. C., Regev, A., & Ebert, B. L. (2014) · Nature Biotechnology · doi:10.1038/nbt.2951 · Cited by 555 · cited 1×
“An improved method to generate liver cancer or myeloid malignancy models in mice facilitated by CRISPR-Cas9 was recently reported ( 98 , 99 ).”
Gene Targeting by Homologous Recombination in Drosophila
Rong, Y. S., & Golic, K. G. (2000) · Science · doi:10.1126/science.288.5473.2013 · Cited by 552
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
Hu, W., Kaminski, R., Yang, F., Zhang, Y., Cosentino, L., Li, F., Luo, B., Alvarez-Carbonell, D., Garcia-Mesa, Y., Karn, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405186111 · Cited by 527 · cited 1×
“targeted CRISPR-Cas9 technique was shown to efficiently cleave and mutate the long terminal repeat sites of HIV-1 and also to remove internal viral genes from the chromosome of infected cells (132, 133).”
Classification and evolution of type II CRISPR-Cas systems
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku241 · Cited by 498 · cited 1×
“Phylogenetic studies ( 69 – 71 ) as well as in vitro and in vivo experiments ( 64 , 71 , 72 ) show that naturally occurring Cas9 orthologs use distinct tracrRNA: crRNA transcripts as guides, defined by the specificity to the dual-RNA structures ( 69 – 71 ) (Fig.”
Self-citationVirus Population Dynamics and Acquired Virus Resistance in Natural Microbial Communities
Andersson, A. F., & Banfield, J. F. (2008) · Science · doi:10.1126/science.1157358 · Cited by 492 · cited 1×
“In natural environments, viruses can be matched to their bacterial or archaeal hosts by examining CRISPR spacers (49, 50).”
Targeted Genome Editing of Sweet Orange Using Cas9/sgRNA
Jia, H., & Wang, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093806 · Cited by 487 · cited 1×
“Since its demonstration as a genome editing tool in Arabidopsis thaliana and Nicotiana benthamiana ( 105 , 106 ), editing has been demonstrated in crop plants including rice, wheat, andsorghumaswellassweetorangeandliverwort ( 107 – 111 ).”
Regulation of gene expression by small molecules
Gottesfeld, J. M., Neely, L., Trauger, J. W., Baird, E. E., & Dervan, P. B. (1997) · Nature · doi:10.1038/387202a0 · Cited by 470
Makarova, K. S., Aravind, L., Wolf, Y. I., & Koonin, E. V. (2011) · Biology Direct · doi:10.1186/1745-6150-6-38 · Cited by 470 · cited 1×
“Within this overall theme, three CRISPRCas system types (I, II, and III) use distinct molecular mechanisms to achieve nucleic acid recognition and cleavage (54, 55).”
Choulika, A., Perrin, A., Dujon, B., & Nicolas, J.-F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1968 · Cited by 460 · cited 1×
“The study of natural DNA repair pathways in bacteria and yeast, as well as the mechanisms of DNA recombination ( 1 – 5 ), revealed that cells have endogenous machinery to repair double-strand DNA breaks (DSBs) that would otherwise be lethal ( 6 – 9 ).”
Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes
Szczelkun, M. D., Tikhomirova, M. S., Sinkunas, T., Gasiunas, G., Karvelis, T., Pschera, P., Siksnys, V., & Seidel, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402597111 · Cited by 453
A CRISPR/Cas system mediates bacterial innate immune evasion and virulence
Sampson, T. R., Saroj, S. D., Llewellyn, A. C., Tzeng, Y.-L., & Weiss, D. S. (2013) · Nature · doi:10.1038/nature12048 · Cited by 443
Nissim, L., Perli, S. D., Fridkin, A., Perez-Pinera, P., & Lu, T. K. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.022 · Cited by 438 · cited 1×
“Nonetheless we prefer to use “CRISPR-Cas9” in a way that is less restrictive than other nomenclatures that have been used in the field (76).”
Xie, S., Shen, B., Zhang, C., Huang, X., & Zhang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100448 · Cited by 417
Jacquier, A., & Dujon, B. (1985) · Cell · doi:10.1016/s0092-8674(85)80011-8 · Cited by 400 · cited 1×
“By inserting desired sequences into the intron first, researchers could incorporate selectedgenetic information into a genome at sites recognized by the homing endonuclease (24, 25).”
RNA-Guided Genome Editing for Target Gene Mutations in Wheat
Upadhyay, S. K., Kumar, J., Alok, A., & Tuli, R. (2013) · G3 Genes|Genomes|Genetics · doi:10.1534/g3.113.008847 · Cited by 392
Selection of chromosomal DNA libraries using a multiplex CRISPR system
Ryan, O. W., Skerker, J. M., Maurer, M. J., Li, X., Tsai, J. C., Poddar, S., Lee, M. E., DeLoache, W., Dueber, J. E., Arkin, A. P., et al. (2014) · eLife · doi:10.7554/elife.03703 · Cited by 373 · cited 1×
“A multiplex CRISPR approach referred to as CRISPRm was developed to facilitate directed evolution of biomolecules (134).”
CasOT: A genome-wide cas9/gRNA off-target searching tool
Xiao, A., Cheng, Z., Kong, L., Zhu, Z., Lin, S., Gao, G., & Zhang, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt764 · Cited by 363
Whitworth, K. M., Lee, K., Benne, J. A., Beaton, B. P., Spate, L. D., Murphy, S. L., Samuel, M. S., Mao, J., O'Gorman, C., Walters, E. M., et al. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121723 · Cited by 354 · cited 1×
“The technology can also facilitate the generation of mouse (120–122) and rat (123, 124) models better suited to pharmacological studies and the understanding of human diseases, as well as pigs (125) andmonkeys (126).”
Makarova, K. S. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.2.482 · Cited by 353
The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems
Chylinski, K., Le Rhun, A., & Charpentier, E. (2013) · RNA Biology · doi:10.4161/rna.24321 · Cited by 353
Self-citationProtospacer recognition motifs: Mixed identities and functional diversity
Shah, S. A., Erdmann, S., Mojica, F. J. M., & Garrett, R. A. (2013) · RNA Biology · doi:10.4161/rna.23764 · Cited by 341
Tang, T.-H., Bachellerie, J.-P., Rozhdestvensky, T., Bortolin, M.-L., Huber, H., Drungowski, M., Elge, T., Brosius, J., & Hüttenhofer, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112047299 · Cited by 337
Fonfara, I., Le Rhun, A., Chylinski, K., Makarova, K. S., Lécrivain, A.-L., Bzdrenga, J., Koonin, E. V., & Charpentier, E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1074 · Cited by 328 · cited 1×
“Phylogenetic studies (69–71) as well as in vitro and in vivo experiments (64, 71, 72) show that naturally occurring Cas9 orthologs use distinct tracrRNA: crRNA transcripts as guides, defined by the specificity to the dual-RNA structures (69–71) (Fig.”
Self-citationMLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
Chen, C., Liu, Y., Rappaport, A. R., Kitzing, T., Schultz, N., Zhao, Z., Shroff, A. S., Dickins, R. A., Vakoc, C. R., Bradner, J. E., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.016 · Cited by 311 · cited 1×
“The ability of CRISPRCas9 to introduce DSBs at defined positions has made it possible to generate human cell lines and primary cells bearing chromosomal translations resembling those described in cancers such as lung cancer (95), acute myeloid leukemia, and Ewing’s sarcoma (96, 97).”
Targeted genomic rearrangements using CRISPR/Cas technology
Choi, P. S., & Meyerson, M. (2014) · Nature Communications · doi:10.1038/ncomms4728 · Cited by 309 · cited 3×
“The ability of CRISPRCas9 to introduce DSBs at defined positions has made it possible to generate human cell lines and primary cells bearing chromosomal translations resembling those described in cancers such as lung cancer (95), acute myeloid leukemia, and Ewing’s sarcoma (96, 97).”
Kearns, N. A., Genga, R. M. J., Enuameh, M. S., Garber, M., Wolfe, S. A., & Maehr, R. (2014) · Development · doi:10.1242/dev.103341 · Cited by 294 · cited 1×
“RNA-programmable S. pyogenes Cas9-mediated editing has now been applied to various human cells and embryonic stem cells [( 87 – 90 ); for reviews, see ( 91 – 93 )].”
Simple and efficient CRISPR/Cas9‐mediated targeted mutagenesis in Xenopus tropicalis
Nakayama, T., Fish, M. B., Fisher, M., Oomen‐Hajagos, J., Thomsen, G. H., & Grainger, R. M. (2013) · genesis · doi:10.1002/dvg.22720 · Cited by 283 · cited 1×
“Efficient genome engineering to allow targeted genome modifications in the germ lines of animal models such as fruit flies ( 113 , 114 ), zebrafish ( 94 , 115 ), nematodes ( 116 ), salamanders ( 117 ), and frogs ( 118 , 119 ) is now possible with the development of the CRISPR-Cas9 technology.”
CRISPR/Cas9-Mediated Targeted Mutagenesis in the Liverwort Marchantia polymorpha L.
Sugano, S. S., Shirakawa, M., Takagi, J., Matsuda, Y., Shimada, T., Hara-Nishimura, I., & Kohchi, T. (2014) · Plant and Cell Physiology · doi:10.1093/pcp/pcu014 · Cited by 269
Ribozyme-mediated repair of defective mRNA by targeted trans-splicing
Sullenger, B. A., & Cech, T. R. (1994) · Nature · doi:10.1038/371619a0 · Cited by 266
Torres, R., Martin, M. C., Garcia, A., Cigudosa, J. C., Ramirez, J. C., & Rodriguez-Perales, S. (2014) · Nature Communications · doi:10.1038/ncomms4964 · Cited by 245 · cited 1×
“TheabilityofCRISPR-Cas9tointroduceDSBsatdefinedpositionshasmadeitpossibletogeneratehumancelllinesand primarycellsbearingchromosomaltranslationsresemblingthosedescribedincancerssuchas lungcancer( 95 ), acute myeloid leukemia, and Ewing ’ s sarcoma ( 96 , 97 ).”
crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus
Karvelis, T., Gasiunas, G., Miksys, A., Barrangou, R., Horvath, P., & Siksnys, V. (2013) · RNA Biology · doi:10.4161/rna.24203 · Cited by 243 · cited 1×
“Phylogenetic studies (69–71) as well as in vitro and in vivo experiments (64, 71, 72) show that naturally occurring Cas9 orthologs use distinct tracrRNA: crRNA transcripts as guides, defined by the specificity to the dual-RNA structures (69–71) (Fig.”
Design, Activity, and Structure of a Highly Specific Artificial Endonuclease
Chevalier, B. S., Kortemme, T., Chadsey, M. S., Baker, D., Monnat, R. J., & Stoddard, B. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00690-1 · Cited by 233
Rudin, N., Sugarman, E., & Haber, J. E. (1989) · Genetics · doi:10.1093/genetics/122.3.519 · Cited by 231
Plessis, A., Perrin, A., Haber, J. E., & Dujon, B. (1992) · Genetics · doi:10.1093/genetics/130.3.451 · Cited by 225
A group II intron RNA is a catalytic component of a DNA endonuclease involved in intron mobility
Zimmerly, S., Guo, H., Eskest, R., Yang, J., Perlman, P. S., & Lambowitz, A. M. (1995) · Cell · doi:10.1016/0092-8674(95)90092-6 · Cited by 214
Nam, K. H., Haitjema, C., Liu, X., Ding, F., Wang, H., DeLisa, M. P., & Ke, A. (2012) · Structure · doi:10.1016/j.str.2012.06.016 · Cited by 212 · cited 1×
“The type I and type III systems use a large complex of Cas proteins for crRNA-guided targeting ( 47 , 59 – 63 ).”
CRISPR: New Horizons in Phage Resistance and Strain Identification
Barrangou, R., & Horvath, P. (2012) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-022811-101134 · Cited by 197 · cited 1×
“existing in cultured bacteria used in the dairy industry couldbeharnessed for immunization against phages—a first successful application of CRISPRCas for biotechnological purposes (46).”
Site-Specific Cleavage of a Yeast Chromosome by Oligonucleotide-Directed Triple-Helix Formation
Strobel, S. A., & Dervan, P. B. (1990) · Science · doi:10.1126/science.2195655 · Cited by 196
Structure of the CRISPR Interference Complex CSM Reveals Key Similarities with Cascade
Rouillon, C., Zhou, M., Zhang, J., Politis, A., Beilsten-Edmands, V., Cannone, G., Graham, S., Robinson, C. V., Spagnolo, L., & White, M. F. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.020 · Cited by 188
Hatoum-Aslan, A., Maniv, I., & Marraffini, L. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112832108 · Cited by 185
Targeted Mutagenesis in Mammalian Cells Mediated by Intracellular Triple Helix Formation
Wang, G., Levy, D. D., Seidman, M. M., & Glazer, P. M. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1759 · Cited by 183
Biallelic genome modification in F0Xenopus tropicalis embryos using the CRISPR/Cas system
Blitz, I. L., Biesinger, J., Xie, X., & Cho, K. W. Y. (2013) · genesis · doi:10.1002/dvg.22719 · Cited by 181 · cited 1×
“Efficient genome engineering to allow targeted genome modifications in the germ lines of animal models such as fruit flies ( 113 , 114 ), zebrafish ( 94 , 115 ), nematodes ( 116 ), salamanders ( 117 ), and frogs ( 118 , 119 ) is now possible with the development of the CRISPR-Cas9 technology.”
Efficient integration of an intron RNA into double-stranded DNA by reverse splicing
Yang, J., Zimmerly, S., Perlman, P. S., & Lambowitz, A. M. (1996) · Nature · doi:10.1038/381332a0 · Cited by 168
Site-Specific Cleavage of Human Chromosome 4 Mediated by Triple-Helix Formation
Strobel, S. A., Doucette-Stamm, L. A., Riba, L., Housman, D. E., & Dervan, P. B. (1991) · Science · doi:10.1126/science.1836279 · Cited by 162 · cited 1×
“…of triple helix formation by Rich and colleagues in the late 1950s ( 10 , 11 ), oligonucleotides coupled to chemical cleavage or cross-linking reagents such as bleo-mycin and psoralen were shown to be useful for site-specific chromosome modification in yeast and mammalian cells ( 12 – 17 ).”
GT-Scan: identifying unique genomic targets
O’Brien, A. R., & Bailey, T. L. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu354 · Cited by 152
To acquire or resist: the complex biological effects of CRISPR–Cas systems
Bondy‐Denomy, J., & Davidson, A. R. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.01.007 · Cited by 144
Genome editing assessment using CRISPR Genome Analyzer (CRISPR-GA)
Güell, M., Yang, L., & Church, G. M. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu427 · Cited by 142
Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells
Faruqi, A. F., Egholm, M., & Glazer, P. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1398 · Cited by 139
Genotyping with CRISPR-Cas-derived RNA-guided endonucleases
Kim, J. M., Kim, D., Kim, S., & Kim, J. (2014) · Nature Communications · doi:10.1038/ncomms4157 · Cited by 134
Single-site enzymatic cleavage of yeast genomic DNA mediated by triple helix formation
Strobel, S. A., & Dervan, P. B. (1991) · Nature · doi:10.1038/350172a0 · Cited by 131
Phage mutations in response to CRISPR diversification in a bacterial population
Sun, C. L., Barrangou, R., Thomas, B. C., Horvath, P., Fremaux, C., & Banfield, J. F. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2012.02879.x · Cited by 115
Heritable Multiplex Genetic Engineering in Rats Using CRISPR/Cas9
Ma, Y., Shen, B., Zhang, X., Lu, Y., Chen, W., Ma, J., Huang, X., & Zhang, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089413 · Cited by 109 · cited 1×
“The technology can also facilitate the generation of mouse (120–122) and rat (123, 124) models better suited to pharmacological studies and the understanding of human diseases, as well as pigs (125) andmonkeys (126).”
Highly efficient targeted mutagenesis in axolotl using Cas9 RNA-guided nuclease
Flowers, G. P., Timberlake, A. T., McLean, K. C., Monaghan, J. R., & Crews, C. M. (2014) · Development · doi:10.1242/dev.105072 · Cited by 102
Recombination Induced by Triple-Helix-Targeted DNA Damage in Mammalian Cells
Faruqi, A. F., Seidman, M. M., Segal, D. J., Carroll, D., & Glazer, P. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6820 · Cited by 100
Sequence-specific inhibition of microRNA via CRISPR/CRISPRi system
Zhao, Y., Dai, Z., Yang, L. H., Yin, M., Ma, K., He, M., Ouyang, H., & Teng, C. (2014) · Scientific Reports · doi:10.1038/srep03943 · Cited by 96
Rong, Z., Zhu, S., Xu, Y., & Fu, X. (2014) · Protein & Cell · doi:10.1007/s13238-014-0032-5 · Cited by 77
Heritable gene-targeting with gRNA/Cas9 in rats
Hu, X., Chang, N., Wang, X., Zhou, F., Zhou, X., Zhu, X., & Xiong, J. (2013) · Cell Research · doi:10.1038/cr.2013.141 · Cited by 57
Cyclic polyamides for recognition in the minor groove of DNA.
Cho, J., Parks, M. E., & Dervan, P. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10389 · Cited by 52
A novel nuclease-ATPase (Nar71) from archaea is part of a proposed thermophilic DNA repair system
Guy, C. P., Majerník, A. I., Chong, J. P. J., & Bolt, E. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh960 · Cited by 36
Discovering the RNA Double Helix and Hybridization
Varshavsky, A. J. (2006) · Cell · doi:10.1016/j.cell.2006.12.008 · Cited by 22 · cited 1×
“Building on the original description of triple helix formation by Rich and colleagues in the late 1950s (10, 11), oligonucleotides coupled to chemical cleavage or cross-linking reagents such as bleo-”
Deficient DNA repair of triple helix‐directed double psoralen damage in human cells
Sándor, Z., & Bredberg, A. C. A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01133-y · Cited by 19 · cited 1×
“…of triple helix formation by Rich and colleagues in the late 1950s ( 10 , 11 ), oligonucleotides coupled to chemical cleavage or cross-linking reagents such as bleo-mycin and psoralen were shown to be useful for site-specific chromosome modification in yeast and mammalian cells ( 12 – 17 ).”
Cited by
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationHigh-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383
Metadata
- Authors
- Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (US)
- Medizinische Hochschule Hannover (DE)
- Corresponding author
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2014-11-28
- Volume
- 346
- Issue
- 6213
- Pages
- 1258096-1258096
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050480410
- Semantic Scholar
- e138728065ae7707ff75c3b6a5a52e81856ccf1b
- Cited by
- 7,062
- References
- 154
- Citations by year
- 2026: 560 · 2025: 716 · 2024: 665 · 2023: 580 · 2022: 689 · 2021: 700 · 2020: 653 · 2019: 578 · 2018: 569 · 2017: 545 · 2016: 471 · 2015: 314 · 2014: 3
- FWCI
- 41.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, genome editing, RNA-guided genome editing, genome modification, genome regulation, biotechnology applications, human therapeutics
- MeSH terms
- Animals, Genetic Engineering, Humans, Genome, Human, Gene Targeting, DNA Cleavage, RNA, Small Untranslated, Clustered Regularly Interspaced Short Palindromic Repeats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.